ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in ProQR Therapeutics N.V. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +1 vs. Q3 2023
- Shares held
- 18.4M
- −324.8K (−1.7%) vs. Q3 2023
- Total value
- $37.0M
- +$12.6M (+51.9%) vs. Q3 2023
- New holders
- 6
- 6 more added
- Sold out
- 5
- 12 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 33 | $65 | 0.00% | 00.0% | Unchanged |
| PFS Partners, LLC | 1,000 | $1.98K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,794 | $3.00K | 0.00% | −12,895−87.8% | Reduced |
| JPMorgan Chase & Co | 1,814 | $3.59K | 0.00% | −145,691−98.8% | Reduced |
| Tower Research Capital LLC (TRC) | 3,536 | $7.00K | 0.00% | +3,536 | New |
| UBS Group AG | 3,900 | $7.72K | 0.00% | −6,144−61.2% | Reduced |
| BlackRock Inc. | 3,945 | $7.81K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 4,600 | $9.00K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 5,860 | $11.0K | 0.00% | −354−5.7% | Reduced |
| Truist Financial Corp | 10,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Vontobel Holding Ltd. | 10,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 10,085 | $20.0K | 0.00% | −47,632−82.5% | Reduced |
| Two Sigma Securities, LLC | 10,637 | $21.1K | 0.00% | +10,637 | New |
| Wells Fargo & Company | 10,996 | $21.8K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 12,811 | $25.4K | 0.00% | −6,650−34.2% | Reduced |
| Atom Investors LP | 13,107 | $26.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 13,967 | $27.7K | 0.00% | −26,643−65.6% | Reduced |
| BNP Paribas Arbitrage, SA | 15,901 | $31.5K | 0.00% | +9,200+137.3% | Added |
| Northern Trust Corp | 17,420 | $34.5K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 18,334 | $36.3K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 18,406 | $36.4K | 0.00% | +8,640+88.5% | Added |
| JustInvest LLC | 21,429 | $42.4K | 0.00% | 00.0% | Unchanged |
| Resources Investment Advisors, LLC. | 31,950 | $63.3K | 0.00% | +12,425+63.6% | Added |
| Bank of Montreal | 30,000 | $66.3K | 0.00% | +30,000 | New |
| Virtu Financial LLC | 34,904 | $69.0K | 0.01% | +34,904 | New |
| Geode Capital Management, LLC | 46,671 | $92.4K | 0.00% | +10,378+28.6% | Added |
| Citadel Advisors LLC | 77,816 | $154.1K | 0.00% | +77,816 | New |
| Bank of America Corp | 78,253 | $154.9K | 0.00% | −30,085−27.8% | Reduced |
| Boothbay Fund Management, LLC | 95,745 | $189.6K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 99,491 | $197.0K | 0.00% | −81,253−45.0% | Reduced |
| Morgan Stanley | 113,711 | $225.1K | 0.00% | −229,247−66.8% | Reduced |
| Squarepoint Ops LLC | 128,174 | $253.8K | 0.00% | −4,204−3.2% | Reduced |
| Franklin Street Advisors Inc | 150,000 | $297.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 168,700 | $334.0K | 0.00% | −59,500−26.1% | Reduced |
| Monaco Asset Management SAM | 378,476 | $749.4K | 0.29% | +959+0.3% | Added |
| Deutsche Bank AG | 385,208 | $762.7K | 0.00% | +385,208 | New |
| Millennium Management LLC | 449,062 | $889.1K | 0.00% | +29,017+6.9% | Added |
| Ikarian Capital, LLC | 472,625 | $935.8K | 0.26% | 00.0% | Unchanged |
| Macquarie Group Ltd | 620,000 | $1.23M | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 940,582 | $1.86M | 0.45% | 00.0% | Unchanged |
| M28 Capital Management LP | 1,910,600 | $3.78M | 3.13% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,980,016 | $5.90M | 0.15% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $7.18M | 0.01% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 5,344,446 | $11.1M | 3.10% | 00.0% | Unchanged |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −189,328−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −74,084−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −20,822−100.0% | Sold out |
| Flaharty Asset Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |